Capital Advisory Group Advisory Services, LLC Edwards Lifesciences Corp Transaction History

Capital Advisory Group Advisory Services, LLC

$210 Million
Q1 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $115,737 - $171,625	-1,338 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$101.96 - $128.34 $136,422 - $171,718	1,338 New	1,338 $158,000
Q4 2021 Feb 15, 2022	SELL	$106.37 - $130.68 $142,323 - $174,849	-1,338 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $51,325 - $68,639	892 Added 200.0%	1,338 $92,000
Q1 2020 May 18, 2020	BUY	$52.41 - $81.0 $23,374 - $36,126	446 New	446 $84,000

Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $31,978 - $36,612	-446 Closed	0 $0
Q1 2019 May 28, 2020	SELL	$47.89 - $64.05 $7,949 - $10,632	-166 Reduced 27.12%	446 $86,000
Q1 2018 May 28, 2020	BUY	$37.19 - $47.45 $22,760 - $29,039	612 New	612 $85,000

Others Institutions Holding EW

# of Institutions

1,378

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $56.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.

Account